⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7422071 | 1.00 | — | — | |
| SCHEMBL190462 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL204916 | 0.98 | EGLN1 (0.59) | — | |
| Bromide SCHEMBL7324484 | 0.98 | EGLN1 (0.59) | — | |
| Acetic Acid SCHEMBL28021124 | 0.92 | EGLN1 (0.53) | — | |
| Acetic Acid SCHEMBL28021125 | 0.92 | EGLN1 (0.53) | — | |
| SCHEMBL11448834 | 0.88 | EGLN1 (0.50) | — | |
| SCHEMBL18439017 | 0.82 | EGLN1 (0.44) | — | |
| SCHEMBL18439015 | 0.82 | EGLN1 (0.44) | — | |
| SCHEMBL13804343 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 691 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025072741-A1 | PRESERVATIVES FOR MOLECULAR SAMPLE ANALYSIS WITH SAMPLE COLLECTION DEVICES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-04-03 | — | — | WO | claimed |
| CN-117530366-A | Antibacterial composition and application thereof | 航天神舟生物科技集团有限公司 | 2024-02-09 | — | — | CN | claimed |
| CN-117388421-A | Method for identifying forage grass rhizosphere secretion and differential metabolite thereof based on non-targeted metabonomics | 中国农业大学 | 2024-01-12 | — | — | CN | claimed |
| EP-3914068-A1 | COMPOSITIONS FOR TREATING CITRUS DISEASE AND PROMOTING YIELD INCREASE IN ROW CROPS | Spogen Biotech Inc. (US) | 2021-12-01 | — | — | EP | claimed |
| CN-113395898-A | Compositions for treating citrus disease and promoting yield enhancement of row crops | 斯波根生物技术公司 | 2021-09-14 | — | — | CN | claimed |
| US-20210080466-A1 | MARKERS FOR THE DIAGNOSIS OF PROSTATE CANCER | BPGBIO, INC. | 2021-03-18 | — | — | US | claimed |
| WO-2020264379-A1 | MARKERS FOR THE DIAGNOSIS OF PROSTATE CANCER | BERG LLC (US) | 2020-12-30 | — | — | WO | claimed |
| US-20200255851-A1 | COMPOSITIONS FOR TREATING CITRUS DISEASE AND PROMOTING YIELD INCREASE IN ROW CROPS | GENISYS CREDIT UNION | 2020-08-13 | — | — | US | claimed |
| CN-111511757-A | Polymeric agonists of mu opioid receptors | 细胞凝胶制药有限责任公司 | 2020-08-07 | — | — | CN | claimed |
| WO-2020154387-A1 | COMPOSITIONS FOR TREATING CITRUS DISEASE AND PROMOTING YIELD INCREASE IN ROW CROPS | SPOGEN BIOTECH INC. (US) | 2020-07-30 | — | — | WO | claimed |
| US-20070185336-A1 | Process for preparing n-protected 4-ketoproline derivatives | DEGUSSA AG (DE) | 2007-08-09 | — | — | US | claimed |
| CN-1939904-A | Production of 4-carbonyl-(S)-proline derivative | SHANGHAI MEDICAL INDUSTRY ACAD (CN) | 2007-04-04 | — | — | CN | claimed |
| CN-1926102-A | Process for the preparation of N-protected 4-ketoproline derivatives | DEGUSSA (DE) | 2007-03-07 | — | — | CN | claimed |
| EP-1720832-A1 | PROCESS FOR PREPARING N-PROTECTED 4-KETOPROLINE DERIVATIVES | Degussa GmbH (DE) | 2006-11-15 | — | — | EP | claimed |
| US-7015306-B2 | Labeled neurotensin derivatives | BIOSYNTHEMA, INC. (US) | 2006-03-21 | — | — | US | claimed |
| WO-2005095340-A1 | PROCESS FOR PREPARING N-PROTECTED 4-KETOPROLINE DERIVATIVES | DEGUSSA AG (DE) | 2005-10-13 | — | — | WO | claimed |
| US-20050191240-A1 | Peptide analogs of neurotensin resistant to enzymatic degradation and retain high binding affinity for neurotensin receptors; metal chelating group on one end; replacing Arg8 with Gly(PipAm) ((N-amidinopiperidinyl)glycine) for example; useful for diagnostic and therapeutic purposes | ADVANCED ACCELERATOR APPLICATIONS USA, INC. | 2005-09-01 | — | — | US | claimed |
| EP-1194444-A2 | LABELED NEUROTENSIN DERIVATIVES WITH IMPROVED RESISTANCE TO ENZYMATIC DEGRADATION | BioSynthema Inc. (US) | 2002-04-10 | — | — | EP | claimed |
| WO-2000078796-A2 | LABELED NEUROTENSIN DERIVATIVES WITH IMPROVED RESISTANCE TO ENZYMATIC DEGRADATION | MALLINCKRODT INC. (US) | 2000-12-28 | — | — | WO | claimed |
| US-5631385-A | Method for the preparation of N-substituted 4-ketoproline derivatives | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1997-05-20 | — | — | US | claimed |